89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in 89bio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- −1 vs. Q2 2021
- Shares held
- 17.3M
- +464.7K (+2.8%) vs. Q2 2021
- Total value
- $339.4M
- +$24.2M (+7.7%) vs. Q2 2021
- New holders
- 3
- 14 more added
- Sold out
- 4
- 19 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 2 | $1.11M |
| Q3 2025 | 198 | $2.27B |
| Q2 2025 | 185 | $1.58B |
| Q1 2025 | 187 | $1.14B |
| Q4 2024 | 156 | $948.7M |
| Q3 2024 | 144 | $773.8M |
| Q2 2024 | 145 | $828.4M |
| Q1 2024 | 150 | $1.14B |
| Q4 2023 | 153 | $1.05B |
| Q3 2023 | 160 | $1.11B |
| Q2 2023 | 157 | $1.46B |
| Q1 2023 | 147 | $1.08B |
| Q4 2022 | 106 | $589.5M |
| Q3 2022 | 86 | $227.3M |
| Q2 2022 | 70 | $104.6M |
| Q1 2022 | 69 | $64.3M |
| Q4 2021 | 50 | $226.1M |
| Q3 2021 | 48 | $339.4M |
| Q2 2021 | 49 | $315.2M |
| Q1 2021 | 67 | $400.6M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding 89bio, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ellevest, Inc. | 3 | $0 | 0.00% | +3 | New |
| Tower Research Capital LLC (TRC) | 416 | $8.00K | 0.00% | −7,776−94.9% | Reduced |
| Ameritas Investment Partners, Inc. | 560 | $11.0K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 820 | $16.0K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,153 | $23.0K | 0.00% | +689+148.5% | Added |
| Simplex Trading, LLC | 3,481 | $64.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,355 | $86.0K | 0.00% | −3,157−42.0% | Reduced |
| California State Teachers Retirement System | 5,250 | $103.0K | 0.00% | −8,186−60.9% | Reduced |
| American International Group, Inc. | 5,335 | $105.0K | 0.00% | −127−2.3% | Reduced |
| SG Americas Securities, LLC | 5,661 | $111.0K | 0.00% | +5,661 | New |
| New York State Common Retirement Fund | 8,196 | $161.0K | 0.00% | +30+0.4% | Added |
| Virtus ETF Advisers LLC | 10,877 | $213.0K | 0.09% | −565−4.9% | Reduced |
| Alliancebernstein L.P. | 14,000 | $274.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 15,645 | $306.0K | 0.00% | −15,872−50.4% | Reduced |
| Glenmede Trust Co NA | 17,929 | $351.0K | 0.00% | 00.0% | Unchanged |
| Bourgeon Capital Management LLC | 22,050 | $432.0K | 0.09% | 00.0% | Unchanged |
| Alps Advisors Inc | 24,613 | $482.0K | 0.00% | −1,808−6.8% | Reduced |
| Charles Schwab Investment Management Inc | 24,809 | $487.0K | 0.00% | −38,037−60.5% | Reduced |
| Gsa Capital Partners LLP | 27,531 | $539.0K | 0.05% | +27,531 | New |
| CSS LLC | 27,945 | $547.0K | 0.03% | +5,000+21.8% | Added |
| Bank of New York Mellon Corp | 30,659 | $600.0K | 0.00% | +2,112+7.4% | Added |
| State of Wisconsin Investment Board | 48,571 | $952.0K | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 51,705 | $1.01M | 0.01% | +2,300+4.7% | Added |
| Nuveen Asset Management, LLC | 60,292 | $1.28M | 0.00% | +5,678+10.4% | Added |
| Deutsche Bank AG | 72,344 | $1.42M | 0.00% | −181−0.2% | Reduced |
| Two Sigma Investments, LP | 77,056 | $1.51M | 0.00% | −24,227−23.9% | Reduced |
| Two Sigma Advisers, LP | 92,000 | $1.80M | 0.00% | −19,800−17.7% | Reduced |
| Pentwater Capital Management LP | 96,000 | $1.88M | 0.03% | 00.0% | Unchanged |
| Royal Bank of Canada | 98,107 | $1.92M | 0.00% | +38,441+64.4% | Added |
| Northern Trust Corp | 103,272 | $2.02M | 0.00% | −18,142−14.9% | Reduced |
| JPMorgan Chase & Co | 121,192 | $2.37M | 0.00% | −1,975−1.6% | Reduced |
| DAFNA Capital Management LLC | 126,652 | $2.48M | 0.66% | +10,200+8.8% | Added |
| Parkman Healthcare Partners LLC | 145,848 | $2.86M | 0.72% | +10,000+7.4% | Added |
| State Street Corp | 147,403 | $2.89M | 0.00% | −925−0.6% | Reduced |
| Orchard Capital Managment, LLC | 150,193 | $2.94M | 0.89% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 178,325 | $3.49M | 0.00% | +21,057+13.4% | Added |
| Pekin Hardy Strauss, Inc. | 184,932 | $3.62M | 0.52% | −44,525−19.4% | Reduced |
| Morgan Stanley | 214,384 | $4.20M | 0.00% | −16,495−7.1% | Reduced |
| Citadel Advisors LLC | 289,854 | $5.68M | 0.01% | −198,911−40.7% | Reduced |
| Candriam Luxembourg S.C.A. | 488,197 | $9.56M | 0.07% | +114,724+30.7% | Added |
| Vanguard Group Inc | 606,914 | $11.9M | 0.00% | +174,979+40.5% | Added |
| FMR LLC | 651,200 | $12.8M | 0.00% | −18,670−2.8% | Reduced |
| BlackRock Inc. | 732,394 | $14.3M | 0.00% | −7,209−1.0% | Reduced |
| Franklin Resources Inc | 806,039 | $15.8M | 0.01% | +44,300+5.8% | Added |
| Eventide Asset Management, LLC | 1,137,092 | $22.3M | 0.29% | 00.0% | Unchanged |
| Wellington Management Group LLP | 1,695,752 | $33.2M | 0.01% | +485,431+40.1% | Added |
| OrbiMed Advisors LLC | 3,729,442 | $73.1M | 0.81% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,965,769 | $97.3M | 1.35% | 00.0% | Unchanged |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −28,032−100.0% | Sold out |
| Penn Mutual Asset Management, LLC | 0 | $0 | 0.00% | −16,190−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,525−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −123−100.0% | Sold out |